𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of the PI3K-AKT kinase pathway in T-cell development beyond the β checkpoint

✍ Scribed by Ling Xue; Leslie Chiang; Chulho Kang; Astar Winoto


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
340 KB
Volume
38
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The PI3K‐AKT pathway can mediate diverse biological responses and is crucial for optimal immune responses and lymphocyte development. Deletion of PI3K subunits or AKT leads to blockage of T‐cell development at the TCR‐β checkpoint. Studies with over‐expression of constitutively activated AKT have implicated this pathway in anti‐apoptosis of developing thymocytes and in development of regulatory T cells. However, the role of endogenous PI3K‐AKT in T‐cell development beyond the TCR‐β checkpoint remains unclear. Here, we inhibited the endogenous PI3K‐AKT pathway in thymocytes after double negative stages by expressing the negative regulator, PTEN. These mice exhibit normal early T‐cell development, but the transition from intermediate single positive to double positive (DP) thymocytes is inhibited, leading to a significantly decreased number of DP, single positive thymocytes and peripheral T cells. Proliferation of peripheral T cells is reduced but apoptosis of DP cells and subsequent T‐cell maturation, including regulatory T cells, are normal. AKT phosphorylation can be readily observed in most WT T‐cell compartments but not DP thymocytes in response to TCR activation. Thus, the PI3K‐AKT pathway is crucial for the transition of intermediate single positive to DP thymocytes but is dispensable for apoptosis and maturation of developing thymocytes.


📜 SIMILAR VOLUMES


Inhibitors of the PI3-kinase/Akt pathway
✍ Therese H Hemström; Margareta Sandström; Boris Zhivotovsky 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 696 KB

## Abstract Non‐small cell lung cancer cells (NSCLC) are more resistant to anticancer treatment as compared with other types of cancer cells. Recently (Hemström __et al__., Exp Cell Res 2005;305:200–13) we showed that apoptosis of U1810 NSCLC cells induced by the staurosporine analog PKC 412 correl

P2 receptor-mediated stimulation of the
✍ H. Franke; C. Sauer; C. Rudolph; U. Krügel; J. G. Hengstler; P. Illes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 965 KB

## Abstract ATP acts as a growth factor as well as a toxic agent by stimulating P2 receptors. The P2 receptor‐activated signaling cascades mediating cellular growth and cell survival after injury are only incompletely understood. Therefore, the aim of the present study was to identify the role of t

Molecular analysis of the PI3K-AKT pathw
✍ Bjørn I. Bertelsen; Solrun J. Steine; Roar Sandvei; Anders Molven; Ole Didrik La 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 363 KB 👁 1 views

## Abstract Uterine cervical carcinogenesis is probably dependent on cellular genetic damage in addition to the integration of high‐risk HPV DNA in the epithelial cell genome. Gain of chromosome 3q24–29 is commonly observed in cervical neoplasia. The putative oncogene __PIK3CA__ located in this reg

Frequent genetic and biochemical alterat
✍ Juana Maria Garcia Pedrero; Dario Garcia Carracedo; Cristina Muñoz Pinto; Agustí 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 247 KB 👁 2 views

## Abstract We investigated the status of the PI 3‐kinase/AKT/PTEN signaling pathway in a series of 117 head and neck squamous cell carcinomas (HNSCC) in a search for molecular alterations in genes/proteins with potential prognostic value. For this purpose, __PIK3CA__ and __AKT2__ gene amplificatio

The Src/PI3K/Akt signal pathway may play
✍ Jiezhong Chen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB

O besity not only results in increased incidence but also leads to poor prognosis of many cancers. The increased cancer incidence in obesity is accounted for by the activation of cellular signal pathways which are carcinogenic such as Src/PI3K/Akt pathway [Chen, 2008; Huang and Chen, 2009b]. However